News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The Fourth Transatlantic Exchange in Oncology – Gustave Roussy
gustaveroussy.fr
Jan 15, 2025, 14:33

The Fourth Transatlantic Exchange in Oncology – Gustave Roussy

Gustave Roussy shared a post on X:

“This conference is part of a collaborative agreement between Dana-Farber and Gustave Roussy, with the support of Servier, a non-profit organisation dedicated to improving healthcare through the promotion of academic research and scientific exchange.

Read the press release.”

The Fourth Transatlantic Exchange in Oncology - Gustave Roussy

cancer Dana-Farber fight against cancer Fourth Transatlantic Exchange Global fight against cancer Gustave Roussy OncoDaily Oncology Servier Transatlantic Exchange
Special Coverage
Insight
Aug 9, 2025, 15:47
Emad Shash: The First Detailed Look at Colorectal Cancer in Southern Egypt
Voices
Aug 9, 2025, 15:46
Martin Zapata Laguado: LOS2025 in São Paulo
Voices
Aug 9, 2025, 15:31
No Two Practices are the Same, and Neither are Their Approaches to Immunotherapy - NCODA
Stories
Aug 9, 2025, 15:19
1,000 Lives, One Message: Never Stop Caring - The Max Foundation
Voices
Aug 9, 2025, 15:05
Al-Ola Abdallah: Cross-Collaboration is Key for Cellular Therapies Options Across Cancer Types
Voices
Aug 9, 2025, 14:56
Are You Passionate About Patient Involvement in Cancer Research? - EORTC
Voices
Aug 9, 2025, 14:53
Aravind Palraj: Immune-Related Adverse Events Can Mimic Cancer Flare
Voices
Aug 9, 2025, 14:51
4 Days to Go Until the NSW Cancer Summit 2025 - Cancer Institute NSW
Societies
Aug 9, 2025, 13:59
AACR Project GENIE 18.0: Genomic Insights from 7,900+ Sarcoma and Bone Cancer Patients
Voices
Aug 9, 2025, 13:48
Nicola Normanno joins "From Policy to Practice" - EAPM
Oncolibrary
Aug 9, 2025, 12:50
FDA Grants Accelerated Approval to Zongertinib for HER2 TKD Mutated Non-Squamous NSCLC
Science
Aug 9, 2025, 12:08
Amol Akhade: Zongertinib - A New Targeted Therapy Option for a Rare Molecular Subset of Lung Cancer